The LXRP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The LXRP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View LXRP Detailed Price Forecast - CNN Money||View LXRP Detailed Summary - Google Finance|
|View LXRP Detailed Summary - Yahoo! Finance||View LXRP Stock Research & Analysis - Zacks.com|
|View LXRP Trends & Analysis - Trade-Ideas||View LXRP Major Holders - Barrons|
|View LXRP Call Transcripts - NASDAQ||View LXRP Breaking News & Analysis - Seeking Alpha|
|View LXRP Annual Report - CompanySpotlight.com||View LXRP OTC Short Report - OTCShortReport.com|
|View LXRP Fundamentals - TradeKing||View LXRP SEC Filings - Bar Chart|
|View Historical Prices for LXRP - The WSJ||View Performance/Total Return for LXRP - Morningstar|
|View the Analyst Estimates for LXRP - MarketWatch||View the Earnings History for LXRP - CNBC|
|View the LXRP Earnings - StockMarketWatch||View LXRP Buy or Sell Recommendations - MacroAxis|
|View the LXRP Bullish Patterns - American Bulls||View LXRP Short Pain Metrics - ShortPainBot.com|
|View LXRP Stock Mentions - StockTwits||View LXRP Stock Mentions - PennyStockTweets|
|View LXRP Stock Mentions - Twitter||View LXRP Investment Forum News - Investor Hub|
|View LXRP Stock Mentions - Yahoo! Message Board||View LXRP Stock Mentions - Seeking Alpha|
|View Insider Transactions for LXRP - SECform4.com||View Insider Transactions for LXRP - Insider Cow|
|View LXRP Major Holdings Summary - CNBC||View Insider Disclosure for LXRP - OTC Markets|
|View Insider Transactions for LXRP - Yahoo! Finance||View Institutional Holdings for LXRP - NASDAQ|
|View LXRP Stock Insight & Charts - FinViz.com||View LXRP Investment Charts - StockCharts.com|
|View LXRP Stock Overview & Charts - BarChart||View LXRP User Generated Charts - Trading View|
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
Posted on Monday March 30, 2020
NEW YORK, March 30, 2020 -- Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at.
Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26
Posted on Tuesday March 24, 2020
Lexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platform today announced that Chris Bunka, Chief Executive Officer, will present live at LifeSciencesInvestorForum.com on March 26. Investigation into its patented DehydraTECH drug delivery technology will be pursued to determine the extent of improvements possible in antiviral drug delivery designed to fight against coronavirus disease COVID-19.
Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020
Posted on Tuesday March 24, 2020
NEW YORK, March 24, 2020 -- Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry.
Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
Posted on Monday March 23, 2020
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / March 23, 2020 / Lexaria Bioscience Corp. (LXRP)(LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp., to investigate how Lexaria's patented DehydraTECHTM drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories in North America and internationally as soon as possible. Within the Lexaria Pharmaceutical Corp. business unit resides Intellectual Property for enhanced delivery of drugs such as non-steroidal anti-inflammatories ("NSAIDs"), vitamins, hormone treatments utilizing estrogen or testosterone and phosphodiesterase ("PDE5") inhibitors; with expansion now underway to include antiviral drugs as well.